OMB control number
Qualitative Feedback on Food and Drug Administration Service Delivery
OMB 0910-0697 · HHS/FDA.
The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with FDA's programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management.
The latest form for Qualitative Feedback on Food and Drug Administration Service Delivery expires 2027-01-31 and can be found here.
Document Name |
|---|
Supplementary Document |
Supplementary Document |
Justification for No Material/Nonsubstantive Change |
Supporting Statement B |
Supporting Statement A |
0697 summaries FINAL.docx
(OC) Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website and FDA Patient Listening Session program |
Approved without change |
Extension without change of a currently approved collection | 2023-11-28 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2022-06-30 | |
|
Approved without change |
Extension without change of a currently approved collection | 2020-11-27 | |
|
Approved without change |
Revision of a currently approved collection | 2017-11-01 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2015-07-22 | |
|
Approved without change |
Extension without change of a currently approved collection | 2014-09-24 | |
|
Approved without change |
New collection (Request for a new OMB Control Number) | 2011-05-26 |
(OC) Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website and FDA Patient Listening Session program
Federal Enterprise Architecture: Health - Consumer Health and Safety